We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR Opdivo
Australian Public Assessment Report
Device/Product Name
Opdivo
Active ingredients
nivolumab
AusPAR Date
Published
Submission Number
PM-2022-00374-1
Submission Type
Extension of indications
Decision
Approved